hyperthyroidism |
Disease ID | 320 |
---|---|
Disease | hyperthyroidism |
Manually Symptom | UMLS | Name(Total Manually Symptoms:255) C2712340 | dyspnoea C2712332 | vomiting C2712323 | hypoglycaemia C2712322 | tachycardia C2711227 | hepatic steatosis C2700526 | erythrocytosis C2678504 | osteoporosis C2676454 | h syndrome C2364377 | delirium C2364324 | increased intracranial pressure C2364133 | infection C2364118 | weakness C2364108 | stigma C2364072 | depression C2364051 | fatigue C2364050 | hypothermia C2348360 | atrial enlargement C2240374 | eosinophilia C2219717 | amenorrhea C2203646 | jaundice C2186532 | liver disease C2108109 | sinus tachycardia C2108077 | atrioventricular block C2048468 | male infertility C2015956 | throat pain C1963279 | viral hepatitis C1963274 | vasculitis C1963235 | sick sinus syndrome C1963220 | pulmonary hypertension C1963165 | malabsorption C1963138 | hypertension C1963135 | hepatic necrosis C1963120 | gynecomastia C1963091 | diarrhea C1963064 | anxiety C1956391 | temporal arteritis C1868682 | paroxysmal kinesigenic choreoathetosis C1839141 | thyroxine-binding globulin deficiency C1704212 | embolism C1619734 | pulmonary arterial hypertension C1609519 | adrenal myelolipoma C1565489 | renal insufficiency C1555754 | cardiovascular disease C1527330 | pyridoxine deficiency C1522057 | duodenitis C1456784 | paranoid disorder C1442871 | craniosynostosis C1442837 | myocardial necrosis C1384672 | hypoparathyroidism C1336753 | thyroid lymphoma C1330961 | acidity C1279412 | periodic paralysis C1135191 | systolic heart failure C1135188 | critical illness myopathy C1059185 | exophthalmus C1000483 | anemia C0948266 | latent tetany C0948008 | ischemic stroke C0920157 | mesenteric ischemia C0917981 | progressive spinal muscular atrophy C0878544 | cardiomyopathy C0851578 | sleep disorders C0848676 | male subfertility C0752303 | urological manifestations C0752303 | urological manifestation C0752196 | ballism C0748159 | pulmonary involvement C0743711 | eye lesion C0741949 | cardiovascular pathology C0740394 | hyperuricemia C0700323 | neuromuscular blockade C0679466 | cognitive deficits C0678222 | breast cancer C0600336 | subcorneal pustular dermatosis C0600086 | toxic goiter C0549473 | thyroid gland carcinoma C0549473 | thyroid carcinoma C0549473 | thyroid cancer C0549473 | carcinoma of the thyroid C0549473 | cancer of the thyroid C0549124 | arterial embolism C0542052 | coronary insufficiency C0497327 | dementia C0494491 | mononeuropathy C0476270 | cardiovascular symptoms C0428908 | sinus node dysfunction C0427008 | stiffness C0426768 | o sign C0424755 | fever C0422833 | ent symptoms C0419203 | osteopathy C0410198 | proximal myopathy C0400916 | acute hepatitis e C0398623 | hypercoagulable state C0398623 | hypercoagulability state C0376293 | stigmata C0342882 | heterozygous familial hypercholesterolemia C0342342 | idiopathic hypoparathyroidism C0339143 | thyroid ophthalmopathy C0338573 | cerebral venous sinus thrombosis C0311223 | frozen shoulder C0277928 | venous hum C0271650 | impaired glucose tolerance C0271650 | glucose intolerance C0270823 | petit mal status C0270739 | hemichorea C0270327 | enuresis C0268445 | normokalemic periodic paralysis C0268283 | disorders of steroid metabolism C0267804 | centrilobular hepatic necrosis C0266928 | rapidly progressive periodontitis C0264886 | conduction disorders C0264757 | rheumatic valvular disease C0264686 | coronary embolism C0262587 | parathyroid adenoma C0243050 | cardiovascular abnormalities C0242342 | sheehan's syndrome C0242292 | mccune-albright syndrome C0241885 | exercise intolerance C0238462 | medullary thyroid carcinoma C0236663 | alcohol withdrawal syndrome C0235527 | right-sided heart failure C0235527 | right heart failure C0235480 | paroxysmal atrial fibrillation C0235430 | ketonaemia C0235401 | abnormal glucose tolerance C0235394 | wasting C0235369 | granulomatous hepatitis C0235250 | hyperemesis C0235169 | excitability C0234132 | pyramidal sign C0233401 | psychiatric symptoms C0233397 | psychological symptoms C0232848 | secondary enuresis C0232197 | fibrillation C0231230 | fatigability C0221505 | cerebral lesions C0221002 | primary hyperparathyroidism C0206682 | follicular carcinoma C0206146 | myocardial stunning C0162568 | erythropoietic protoporphyria C0162565 | acute intermittent porphyria C0162316 | iron deficiency anemia C0156259 | renal hypertrophy C0155301 | retrobulbar neuritis C0152171 | primary pulmonary hypertension C0152171 | idiopathic pulmonary hypertension C0152025 | polyneuropathy C0151945 | cerebral venous thrombosis C0151798 | liver necrosis C0151744 | myocardial ischemia C0149670 | disorders of carbohydrate metabolism C0085681 | hyperphosphatemia C0085681 | hyperphosphataemia C0085661 | onycholysis C0085655 | polymyositis C0085583 | choreoathetosis C0043117 | idiopathic thrombocytopenic purpura C0043117 | autoimmune thrombocytopenic purpura C0042024 | loss of bladder control C0041326 | pleural tuberculosis C0040149 | subacute thyroiditis C0040137 | thyroid nodules C0040034 | thrombocytopenia C0039621 | tetany C0038478 | struma ovarii C0038238 | steatorrhoea C0038218 | status asthmaticus C0038013 | ankylosing spondylitis C0037763 | muscle spasms C0037672 | sleepwalking C0035579 | rickets C0035435 | rheumatism C0034150 | purpura C0034063 | pulmonary edema C0033774 | pruritus C0033103 | pretibial myxedema C0033038 | premature ejaculation C0032617 | polyuria C0032000 | pituitary adenomas C0031117 | peripheral neuropathy C0030552 | muscle pareses C0030517 | parathyroid disease C0030312 | pancytopenia C0029458 | postmenopausal bone loss C0029132 | optic neuropathies C0029089 | oculomotor paralysis C0027947 | neutropenia C0027868 | neuromuscular disorders C0027726 | nephrotic syndrome C0027145 | myxoedema C0027145 | myxedema C0027126 | myotonic dystrophy C0027066 | myoclonus C0027051 | myocardial infarction C0026896 | myasthenia gravis C0026848 | myopathy C0026848 | myopathies C0026848 | muscular disorders C0026848 | muscular diseases C0026846 | muscle wasting C0026650 | movement disorders C0026267 | mitral valve prolapse C0026266 | mitral regurgitation C0025517 | metabolism disorder C0025517 | metabolic disorders C0024141 | systemic lupus erythematosus C0023895 | hepatic pathology C0022972 | lambert-eaton syndrome C0022354 | cholestatic jaundice C0020640 | hypoprothrombinemia C0020615 | hypoglycemia C0020505 | hyperphagia C0020502 | hyperparathyroidism C0020456 | hyperglycemia C0020437 | hypercalcemia C0020437 | hypercalcaemia C0020217 | molar pregnancy C0019158 | hepatitis C0018817 | atrial septal defect C0018802 | congestive heart failure C0018801 | heart failure C0018801 | cardiac insufficiency C0018801 | cardiac failure C0018799 | cardiac disorders C0018794 | heart block C0018418 | gynaecomastia C0018213 | graves-basedow disease C0018213 | graves' disease C0018021 | goitre C0018021 | goiter C0016065 | polyostotic fibrous dysplasia C0015300 | exophthalmos C0012569 | diplopia C0012242 | digestive diseases C0011880 | diabetic ketosis C0011860 | diabetes C0011849 | diabetes mellitus C0011168 | dysphagia C0010073 | coronary vasospasm C0010073 | coronary artery spasm C0008497 | choriocarcinoma C0008489 | chorea C0008372 | intrahepatic cholestasis C0008312 | primary biliary cirrhosis C0007222 | cardiovascular disorders C0007193 | dilated cardiomyopathy C0005779 | blood coagulation disorders C0005586 | bipolar disorder C0004936 | mental disorders C0004364 | autoimmune disorder C0004245 | av blocks C0003811 | rhythm disorder C0002892 | pernicious anaemia C0001403 | addison's disease |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:75) C0018213 | graves' disease | 21 C0232197 | fibrillation | 16 C0018021 | goiter | 14 C0018801 | heart failure | 9 C0020538 | hypertension | 9 C0011847 | diabetes | 6 C0007115 | thyroid cancer | 5 C0018021 | goitre | 5 C0878544 | cardiomyopathy | 4 C0030312 | pancytopenia | 4 C0029456 | osteoporosis | 4 C0018802 | congestive heart failure | 3 C0039231 | tachycardia | 3 C0398623 | hypercoagulable state | 3 C0030443 | periodic paralysis | 3 C0235250 | hyperemesis | 3 C0020542 | pulmonary hypertension | 3 C0004093 | weakness | 3 C0011168 | dysphagia | 2 C0040147 | thyroiditis | 2 C0020217 | molar pregnancy | 2 C0013922 | embolism | 2 C0026848 | muscular disorders | 2 C0022346 | jaundice | 2 C0018801 | cardiac failure | 2 C0549473 | thyroid carcinoma | 2 C0010278 | craniosynostosis | 2 C0020437 | hypercalcemia | 2 C0026848 | myopathy | 2 C0023895 | liver disease | 2 C0009450 | infection | 2 C0027051 | myocardial infarction | 2 C0497327 | dementia | 2 C0011570 | depression | 2 C0007222 | cardiovascular disorders | 2 C0040137 | thyroid nodules | 1 C0221002 | primary hyperparathyroidism | 1 C0152025 | polyneuropathy | 1 C0085655 | polymyositis | 1 C0410198 | proximal myopathy | 1 C0020456 | hyperglycemia | 1 C0042963 | vomiting | 1 C0948008 | ischemic stroke | 1 C0085681 | hyperphosphatemia | 1 C0027126 | myotonic dystrophy | 1 C0426768 | o sign | 1 C0042721 | viral hepatitis | 1 C0019158 | hepatitis | 1 C0151740 | increased intracranial pressure | 1 C0020672 | hypothermia | 1 C0233401 | psychiatric symptoms | 1 C0032000 | pituitary adenomas | 1 C0262587 | parathyroid adenoma | 1 C0151945 | cerebral venous thrombosis | 1 C0002871 | anemia | 1 C0241885 | exercise intolerance | 1 C0270739 | hemichorea | 1 C1527405 | erythrocytosis | 1 C0004096 | asthma | 1 C0020502 | hyperparathyroidism | 1 C0206682 | follicular carcinoma | 1 C0339143 | thyroid ophthalmopathy | 1 C0026896 | myasthenia gravis | 1 C0027145 | myxedema | 1 C0235480 | paroxysmal atrial fibrillation | 1 C0159069 | impaired glucose tolerance | 1 C0042384 | vasculitis | 1 C0027868 | neuromuscular disorders | 1 C0008489 | chorea | 1 C0020505 | hyperphagia | 1 C0033038 | premature ejaculation | 1 C0235527 | right heart failure | 1 C0152171 | idiopathic pulmonary hypertension | 1 C0005586 | bipolar disorder | 1 C1619734 | pulmonary arterial hypertension | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:3) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs121908873 | 18466076 | 7253 | TSHR | umls:C0020550 | BeFree | Interestingly, an additional constitutively active somatic mutation (S281N) was identified on the second parental TSHR allele of the hyperthyroid index patient. | 0.152642545 | 2008 | TSHR;LOC101928462 | 14 | 81139828 | G | A,T |
rs17879469 | 22968483 | 26191 | PTPN22 | umls:C0020550 | BeFree | Evaluation of genotypes (HLA DRB1*03, DQA1*05, DQB1*02; CTLA4 49A/G, CT60 A/G; PTPN22 C/T) in relation to phenotypes (age, sex, severity (clinical, biochemical, and immunological)) of hyperthyroidism and environmental factors (smoking, stress questionnaires). | 0.000271442 | 2012 | HLA-DRB1;LOC105369230 | 6 | 32584333 | C | G |
rs17879469 | 22968483 | 3123 | HLA-DRB1 | umls:C0020550 | BeFree | Evaluation of genotypes (HLA DRB1*03, DQA1*05, DQB1*02; CTLA4 49A/G, CT60 A/G; PTPN22 C/T) in relation to phenotypes (age, sex, severity (clinical, biochemical, and immunological)) of hyperthyroidism and environmental factors (smoking, stress questionnaires). | 0.000271442 | 2012 | HLA-DRB1;LOC105369230 | 6 | 32584333 | C | G |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:11) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0020550 | carbimazole | D002231 | 22232-54-8 | hyperthyroidism | MESH:D006980 | therapeutic | 12549952 | ||
C0020550 | glutathione | D005978 | 70-18-8 | hyperthyroidism | MESH:D006980 | marker/mechanism | 19914224 | ||
C0020550 | peginterferon alfa-2a | C100416 | - | hyperthyroidism | MESH:D006980 | marker/mechanism | 18097301 | ||
C0020550 | propranolol | D011433 | 525-66-6 | hyperthyroidism | MESH:D006980 | therapeutic | 11193444 | ||
C0020550 | propylthiouracil | D011441 | 51-52-5 | hyperthyroidism | MESH:D006980 | marker/mechanism | 12621104 | ||
C0020550 | propylthiouracil | D011441 | 51-52-5 | hyperthyroidism | MESH:D006980 | therapeutic | 11014318 | ||
C0020550 | reserpine | D012110 | 50-55-5 | hyperthyroidism | MESH:D006980 | therapeutic | 4589407 | ||
C0020550 | ribavirin | D012254 | 36791-04-5 | hyperthyroidism | MESH:D006980 | marker/mechanism | 18097301 | ||
C0020550 | rifampin | D012293 | 13292-46-1 | hyperthyroidism | MESH:D006980 | marker/mechanism | 16236685 | ||
C0020550 | sotalol | D013015 | 3930-20-9 | hyperthyroidism | MESH:D006980 | marker/mechanism | 83509 | ||
C0020550 | vitamin e | D014810 | 1406-18-4 | hyperthyroidism | MESH:D006980 | therapeutic | 19914224 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |